<!DOCTYPE html><html><head>   <meta>     <title>How a new FDA requirement could help identify more breast cancer cases</title>   </meta>   <style>
.youtube_player_container {
    position: relative;
    width: 50%;
    padding-bottom: 26.25%;
    /* background-color: yellow; */
}
.youtube_player_frame {
    position: absolute;
    top: 0;
    left: 0;
    width: 100%;
    height: 100%;
    border: 0;
}
       </style></head><body><a href="index.html"><h2>Index</h2></a><a href="https://www.pbs.org/newshour/show/how-a-new-fda-requirement-could-help-identify-more-breast-cancer-cases"><div><img style="width:400px;height=300px" src="https://d3i6fh83elv35t.cloudfront.net/static/2024/09/DetectingCancer-1024x576.jpg" /></div><h1>[1146425] How a new FDA requirement could help identify more breast cancer cases</h1></a><div></div><div>2024-09-14 17:40:15+00:00</div><div><pre>About 1 in 8 women will be diagnosed with breast cancer in her lifetime. That’s one reason doctors recommend women get yearly mammograms beginning at age 45, but for some women, mammograms won’t detect their cancer. A new FDA requirement could lead to more breast cancer cases being identified, saving lives. JoAnn Pushkin, executive director of DenseBreast-info.org, joins Ali Rogin to discuss.</pre></div></body></html>